Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms222111905
Abstract: Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic pathology in industrialized countries, affecting about 25% of the general population. NAFLD is a benign condition, however, it could evolve toward more serious diseases, including… read more here.
Keywords: clinical molecular; diagnosis staging; staging nafld; molecular biomarkers ... See more keywords